Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Jun;35(6):1575–1578. doi: 10.1128/jcm.35.6.1575-1578.1997

Dot immunoperoxidase assay for detection of parvovirus B19 antigens in serum samples.

G Gentilomi 1, M Musiani 1, M Zerbini 1, G Gallinella 1, S Venturoli 1, E Manaresi 1
PMCID: PMC229790  PMID: 9163485

Abstract

We describe a simple and rapid dot immunoperoxidase assay for the direct detection of parvovirus B19 capsid antigens in human sera. The assay was performed with serum specimens dotted onto nylon membranes. VP1 and VP2 B19 antigens, which represent 4 and 96% of the capsid, respectively, were detected with a pool of monoclonal antibodies directed against the two proteins, and the complex was visualized by immunoperoxidase staining. The assay could be performed in about 4 h, and positive results were revealed at the end of the reaction as dark blue spots on the nylon membrane at the site of positive specimens. A total of 541 serum samples from different subjects and with different laboratory evaluations with regard to B19 infection were analyzed. The results obtained by the dot immunoperoxidase assay were compared with the results obtained for the presence of B19 DNA by dot blot hybridization and nested PCR. With optimized working conditions, the dot immunoperoxidase assay was able to detect the presence of B19 with a sensitivity comparable or slightly higher than that achieved by dot blot hybridization but less than that achieved by nested PCR. Since the level of sensitivity of the dot immunoperoxidase assay proved to be appropriate for the detection of acute B19 infection, and since the cost, time to a result, and versatility of the assay are important issues, from our evaluation, the dot immunoperoxidase assay described may be particularly suitable for large-scale screening of samples and a good alternative to DNA detection methods in the routine laboratory evaluation of B19 infection.

Full Text

The Full Text of this article is available as a PDF (312.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson L. J. Human parvoviruses. J Infect Dis. 1990 Apr;161(4):603–608. doi: 10.1093/infdis/161.4.603. [DOI] [PubMed] [Google Scholar]
  2. Azzi A., Zakrzewska K., Gentilomi G., Musiani M., Zerbini M. Detection of B19 parvovirus infections by a dot-blot hybridization assay using a digoxigenin-labelled probe. J Virol Methods. 1990 Feb;27(2):125–133. doi: 10.1016/0166-0934(90)90129-4. [DOI] [PubMed] [Google Scholar]
  3. Berry P. J., Gray E. S., Porter H. J., Burton P. A. Parvovirus infection of the human fetus and newborn. Semin Diagn Pathol. 1992 Feb;9(1):4–12. [PubMed] [Google Scholar]
  4. Brown K. E., Young N. S., Liu J. M. Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol. 1994 Feb;16(1):1–31. doi: 10.1016/1040-8428(94)90040-x. [DOI] [PubMed] [Google Scholar]
  5. Cassinotti P., Weitz M., Siegl G. Human parvovirus B19 infections: routine diagnosis by a new nested polymerase chain reaction assay. J Med Virol. 1993 Jul;40(3):228–234. doi: 10.1002/jmv.1890400311. [DOI] [PubMed] [Google Scholar]
  6. Durigon E. L., Erdman D. D., Gary G. W., Pallansch M. A., Torok T. J., Anderson L. J. Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. J Virol Methods. 1993 Oct;44(2-3):155–165. doi: 10.1016/0166-0934(93)90051-r. [DOI] [PubMed] [Google Scholar]
  7. Field A. M., Cohen B. J., Brown K. E., Mori J., Clewley J. P., Nascimento J. P., Hallam N. F. Detection of B19 parvovirus in human fetal tissues by electron microscopy. J Med Virol. 1991 Oct;35(2):85–95. doi: 10.1002/jmv.1890350204. [DOI] [PubMed] [Google Scholar]
  8. Gallinella G., Musiani M., Zerbini M., Gentilomi G., Gibellini D., Venturoli S., La Placa M. Efficient parvovirus B19 DNA purification and molecular cloning. J Virol Methods. 1993 Feb;41(2):203–211. doi: 10.1016/0166-0934(93)90127-d. [DOI] [PubMed] [Google Scholar]
  9. Heegaard E. D., Hornsleth A. Parvovirus: the expanding spectrum of disease. Acta Paediatr. 1995 Feb;84(2):109–117. doi: 10.1111/j.1651-2227.1995.tb13591.x. [DOI] [PubMed] [Google Scholar]
  10. Hicks K. E., Beard S., Cohen B. J., Clewley J. P. A simple and sensitive DNA hybridization assay used for the routine diagnosis of human parvovirus B19 infection. J Clin Microbiol. 1995 Sep;33(9):2473–2475. doi: 10.1128/jcm.33.9.2473-2475.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mosley J. W. Should measures be taken to reduce the risk of human parvovirus (B19) infection by transfusion of blood components and clotting factor concentrates? Transfusion. 1994 Sep;34(9):744–746. doi: 10.1046/j.1537-2995.1994.34994378271.x. [DOI] [PubMed] [Google Scholar]
  12. Musiani M., Azzi A., Zerbini M., Gibellini D., Venturoli S., Zakrzewska K., Re M. C., Gentilomi G., Gallinella G., La Placa M. Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patients. J Med Virol. 1993 Jun;40(2):157–160. doi: 10.1002/jmv.1890400214. [DOI] [PubMed] [Google Scholar]
  13. Musiani M., Zerbini M., Gentilomi G., Plazzi M., Gallinella G., Venturoli S. Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis. 1995 Nov;172(5):1360–1363. doi: 10.1093/infdis/172.5.1360. [DOI] [PubMed] [Google Scholar]
  14. Musiani M., Zerbini M., Gentilomi G., Rodorigo G., De Rosa V., Gibellini D., Venturoli S., Gallinella G. Persistent B19 parvovirus infections in haemophilic HIV-1 infected patients. J Med Virol. 1995 Jun;46(2):103–108. doi: 10.1002/jmv.1890460204. [DOI] [PubMed] [Google Scholar]
  15. Musiani M., Zerbini M., Gibellini D., Gentilomi G., Venturoli S., Gallinella G., Ferri E., Girotti S. Chemiluminescence dot blot hybridization assay for detection of B19 parvovirus DNA in human sera. J Clin Microbiol. 1991 Sep;29(9):2047–2050. doi: 10.1128/jcm.29.9.2047-2050.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pattison J. R. Human parvovirus B19. BMJ. 1994 Jan 15;308(6922):149–150. doi: 10.1136/bmj.308.6922.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Zerbini M., Musiani M., Gentilomi G., La Placa M. Dot immunoperoxidase assay using monoclonal antibody for direct detection of cytomegalovirus in urine samples. J Clin Microbiol. 1987 Nov;25(11):2197–2199. doi: 10.1128/jcm.25.11.2197-2199.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Zerbini M., Musiani M., Gibellini D., Gentilomi G., Venturoli S., Gallinella G., La Placa M. Evaluation of strand-specific RNA probes visualized by colorimetric and chemiluminescent reactions for the detection of B19 parvovirus DNA. J Virol Methods. 1993 Dec 15;45(2):169–178. doi: 10.1016/0166-0934(93)90101-v. [DOI] [PubMed] [Google Scholar]
  19. Zerbini M., Musiani M., Venturoli S., Gallinella G., Gibellini D., Gentilomi G., La Placa M. Rapid screening for B19 parvovirus DNA in clinical specimens with a digoxigenin-labeled DNA hybridization probe. J Clin Microbiol. 1990 Nov;28(11):2496–2499. doi: 10.1128/jcm.28.11.2496-2499.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES